1. N06 Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic: results from a Belgian tertiary IBD unit. (27th May 2021) Authors: Dewitte, G; Geldof, J; Truyens, M; Lobaton, T Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP19 Classifying perianal fistulising Crohn's Disease: An expert-consensus to guide decision-making in daily practice and clinical trials. (21st January 2022) Authors: Geldof, J; Iqbal, N; LeBlanc, J F; Sawyer, R; Buskens, C; Bemelman, W; Gecse, K; Lundby, L; Lightner, A L; Danese, S; Spinelli, A; Carvello, M; Faiz, O; Warusavitarne, J; Lung, P; De Looze, D; D'Hoore, A; Vermeire, S; Hart, A; Tozer, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P095 Initial disease course in a Belgian, prospective inception cohort of patients with inflammatory bowel disease: the PANTHER cohort. (27th May 2021) Authors: Verstockt, S; Glorieus, E; Ukunda, C; Barbaraci, M; Verstockt, B; Sabino, J; Ferrante, M; Geldof, J; De Vos, M; Laukens, D; Cleynen, I; Vandermeulen, L; Lobatón, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P266 The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort study. (27th May 2021) Authors: Truyens, M; De Galan, C; Peeters, H; Mesonero Gismero, F; Elorza, A; Torres, P; Vandermeulen, L; Jauregui Amezaga, A; Ferreiro-Iglesias, R; Holvoet, T; Zabana, Y; Peries Reverter, L; Geldof, J; Varkas, G; De Vos, M; Lobaton, T Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P283 Infliximab re-challenge: could it be an option in refractory IBD patients?. (21st January 2022) Authors: Truyens, M; Pijoan Comas, E; Glorieus, E; Geldof, J; Lobatón Ortega, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P440 First results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (27th May 2021) Authors: Geldof, J; Truyens, M; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P529 Evolution of COVID19 serology in a real-life population of IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (21st January 2022) Authors: Geldof, J; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P583 The prevalence of side effects to immunomodulators and biologics in patients with Crohn's disease intestinal failure compared with Crohn's disease without intestinal failure. (15th January 2020) Authors: Bouri, S; Geldof, J; Willsmore, J; Donnelly, S; Gabe, S; Hart, A Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P593 Impact of immunomodulating treatment modalities, active smoking and (repeated) COVID19 vaccination on S-antibody seroconversion in IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (30th January 2023) Authors: Geldof, J; Truyens, M; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; de Vlam, K; Verschueren, P; Padalko, E; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P664 The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients: A real-life experience of a single-centre cohort. (15th January 2020) Authors: TRUYENS, M; Geldof, J; Dewitte, G; Glorieus, E; Varkas, G; Elewaut, D; Lobaton Ortega, T Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗